The popularity of Sildenafil initially sparked a period of growth for pharma, nevertheless recent shifts present a uncertain scenario for those considering a stake. Generic versions are eating into revenue, and https://berthatcmm348209.bluxeblog.com/73587900/sildenafil-and-the-pharmaceutical-industry-a-risky-investment